This announcement is a separate document:
康弘药业：关于调整公司2022年股票增值权激励计划行权价格的公告
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2022 Stock Value-added Rights Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.